Number of Shares
416,371.00
Current Holdings Value*
$10.10 Mil
% of Portfolio
4.99%
Total Estimate Gain
$7.98 Mil
% of Total Estimate Gain
293.62%

GABLES CAPITAL MANAGEMENT INC.'s Catalyst Pharmaceuticals Inc Holding Summary

As of 2025-03-31, GABLES CAPITAL MANAGEMENT INC. held 416,371.00 shares of Catalyst Pharmaceuticals Inc(CPRX), totaling $10.10 Mil. This investment constitutes 4.99% of their stock portfolio, and GABLES CAPITAL MANAGEMENT INC. now holds 0.34% of the outstanding Catalyst Pharmaceuticals Inc(CPRX) stock.

The initial trade took place in 2018Q2. And since then GABLES CAPITAL MANAGEMENT INC. has made 10 purchases of CPRX, at an average price of $4.14, for a total of 656,619.00 shares. In addition, there have been 18 sales at an average price of $7.14 for 240,248.00 shares. Based on historical transaction data and CPRX's current price of $21.57, GABLES CAPITAL MANAGEMENT INC.'s estimated gain on his CPRX holdings is $7.98 Mil, reflecting a 293.62% gain to date.

GABLES CAPITAL MANAGEMENT INC. CPRX ($21.57) Holding Chart

GABLES CAPITAL MANAGEMENT INC. CPRX ($21.57) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1